REQUEST A DEMO
Total
USD $0.00
Search more companies

Riddhi Pharma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Riddhi Pharma S A S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Riddhi Pharma S A S is based in Colombia, with the head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on February 27, 2007. There are currently 17 (2025) people employed by Riddhi Pharma S A S. From the latest financial highlights, Riddhi Pharma S A S reported a net sales revenue drop of 11.19% in 2024. Its total assets decreased by 6.69% over the same period. The net profit margin of Riddhi Pharma S A S decreased by 0.7% in 2024.

Headquarters
Carrera 69 B 77 61
Bogota D.C.; Bogota D.C; Postal Code: 0904

Contact Details: Purchase the Riddhi Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Riddhi Pharma S A S report to view the information.
Financial Auditors:
Purchase the Riddhi Pharma S A S report to view the information.
Incorporation Date:
February 27, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Riddhi Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-11.19%
Total operating revenue
-11.19%
Operating profit (EBIT)
-63.81%
Net Profit (Loss) for the Period
-63.81%
Total Assets
-6.69%
Total Equity
1.3%
Operating Profit Margin (ROS)
-0.7%
Net Profit Margin
-0.7%
Return on Equity (ROE)
-2.31%
Quick Ratio
0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?